Now we're exploring arrhythmias, disorders of the heart's electrical system that can range from harmless palpitations to life-threatening emergencies. Think of the heart's conduction system as an intricate electrical grid; when this system malfunctions, the heart's rhythm becomes disrupted. I'll guide you through the mechanisms, classification, diagnosis, and management of these fascinating but complex conditions. Understanding arrhythmias is essential as they affect millions and require both acute intervention and long-term management strategies. Let's decode the heart's electrical language!
π©Ί Basic Cardiac Electrophysiology Review
Before diving into arrhythmias, let's quickly review the normal cardiac conduction system and action potentials - this foundation is crucial for understanding what goes wrong in arrhythmias.
Conduction Pathway
- SA node: Primary pacemaker (60-100 bpm)
- AV node: Gatekeeper, delays impulse
- Bundle of His: Connects atria to ventricles
- Purkinje fibers: Rapid ventricular activation
Action Potential Types
- Phase 4: Spontaneous depolarization (pacemaker cells)
- Phase 0: Rapid depolarization (fast Na+ channels)
- Phases 1-3: Repolarization (K+ efflux)
- Refractory periods: Absolute and relative
| Cell Type | Automaticity | Conduction Velocity | Action Potential Duration |
|---|---|---|---|
| SA Node | High (primary pacemaker) | Slow (0.05 m/s) | Short |
| Atrial Muscle | None | Fast (1 m/s) | Medium |
| AV Node | Moderate (40-60 bpm) | Very slow (0.05 m/s) | Medium |
| Ventricular Muscle | None | Fast (1 m/s) | Long |
| Purkinje Fibers | Low (20-40 bpm) | Very fast (4 m/s) | Long |
π Mechanisms of Arrhythmogenesis
Arrhythmias develop through three primary mechanisms: abnormalities in impulse formation, abnormalities in impulse conduction, or combinations of both.
Enhanced Automaticity
- Increased phase 4 depolarization
- Ectopic pacemaker activity
- Causes: catecholamines, ischemia, electrolyte abnormalities
- Examples: sinus tachycardia, atrial tachycardia
Triggered Activity
- Afterdepolarizations (early/delayed)
- Occurs during/after repolarization
- Causes: drugs (digoxin), long QT, ischemia
- Examples: torsades de pointes, digoxin toxicity
Reentry Circuits
- Most common mechanism
- Requires: two pathways, unidirectional block, slow conduction
- Causes: scar tissue, accessory pathways
- Examples: AVNRT, atrial flutter, VT
π Classification of Arrhythmias
Arrhythmias are classified based on their origin (supraventricular vs ventricular), rate (bradycardia vs tachycardia), and regularity.
Major Arrhythmia Categories
| Category | Rate | Origin | Common Examples | Clinical Significance |
|---|---|---|---|---|
| Bradyarrhythmias | <60 bpm | SA node, AV node | Sinus bradycardia, heart block | May cause syncope, fatigue |
| Supraventricular Tachycardias | >100 bpm | Above bundle of His | AFib, AFL, AVNRT, AVRT | Palpitations, rarely immediately life-threatening |
| Ventricular Tachycardias | >100 bpm | Ventricles | VT, VF, torsades | Potentially life-threatening, can degrade to VF |
| Conduction Disorders | Variable | Conduction system | Bundle branch blocks, heart blocks | May progress to complete heart block |
Narrow Complex Tachycardias (QRS <120 ms)
- Sinus tachycardia: Normal response
- Atrial fibrillation: Irregularly irregular
- Atrial flutter: Sawtooth pattern
- AVNRT/AVRT: Regular, abrupt onset/termination
Wide Complex Tachycardias (QRS >120 ms)
- Ventricular tachycardia: Regular, AV dissociation
- SVT with aberrancy: Supraventricular origin
- Pre-excited AF: WPW with AF, can be fatal
- Paced rhythm: Pacemaker spikes
π¨ββοΈ Common Arrhythmias: Clinical Features
Different arrhythmias present with characteristic symptoms, ECG findings, and clinical implications. Recognition is key to appropriate management.
Key Arrhythmia Profiles
| Arrhythmia | ECG Features | Symptoms | Acute Management | Long-term Management |
|---|---|---|---|---|
| Atrial Fibrillation | Irregularly irregular, no P waves | Palpitations, dyspnea, fatigue | Rate control, cardioversion if unstable | Anticoagulation, rhythm control |
| Atrial Flutter | Sawtooth flutter waves, regular ventricular response | Palpitations, similar to AFib | Rate control, cardioversion | Anticoagulation, ablation |
| AVNRT | Regular, narrow complex, P waves buried in QRS | Palpitations, neck pounding, anxiety | Vagal maneuvers, adenosine | Ablation, medications |
| Ventricular Tachycardia | Wide QRS, AV dissociation, rate >100 | Palpitations, syncope, chest pain | Cardioversion/defibrillation, amiodarone | ICD, antiarrhythmics, ablation |
| Complete Heart Block | AV dissociation, atrial rate > ventricular rate | Syncope, fatigue, heart failure | Atropine, temporary pacing | Permanent pacemaker |
π Diagnostic Approach
Diagnosing arrhythmias requires capturing the abnormal rhythm, identifying underlying causes, and assessing hemodynamic consequences.
Diagnostic Tools
| Test | Indication | Advantages | Limitations |
|---|---|---|---|
| 12-lead ECG | Initial evaluation, acute symptoms | Immediate, identifies ischemia, morphology | Brief snapshot, may miss paroxysmal arrhythmias |
| Holter Monitor | Frequent symptoms (daily) | 24-48 hour continuous recording | Limited duration, may miss infrequent events |
| Event Monitor | Intermittent symptoms (weekly-monthly) | Worn for 30 days, patient-activated | Requires patient to trigger during symptoms |
| Implantable Loop Recorder | Infrequent symptoms, unexplained syncope | Monitors for 2-3 years, automatic detection | Invasive, cost |
| Electrophysiology Study | Risk stratification, guide ablation | Precise diagnosis, can treat during procedure | Invasive, procedural risks |
π Management Strategies
Arrhythmia management involves acute termination of unstable rhythms, chronic prevention of recurrences, and reducing thromboembolic risk in atrial arrhythmias.
Antiarrhythmic Medications (Vaughan Williams Classification)
| Class | Mechanism | Examples | Main Uses | Key Side Effects |
|---|---|---|---|---|
| Class I (Na+ channel blockers) | Slow conduction | Flecainide, Propafenone | AFib, SVT (no structural heart disease) | Proarrhythmia, negative inotropy |
| Class II (Beta-blockers) | Reduce automaticity, slow AV conduction | Metoprolol, Atenolol | Rate control in AFib, sinus tachycardia | Bradycardia, fatigue, bronchospasm |
| Class III (K+ channel blockers) | Prolong repolarization | Amiodarone, Sotalol | AFib, VT, life-threatening arrhythmias | QT prolongation, organ toxicity (amiodarone) |
| Class IV (Ca2+ channel blockers) | Slow AV node conduction | Verapamil, Diltiazem | Rate control in AFib, AVNRT | Hypotension, constipation, heart failure |
| Other | Various mechanisms | Digoxin, Adenosine | Rate control (digoxin), acute SVT (adenosine) | Narrow therapeutic window (digoxin) |
Non-Pharmacological Therapies
Device Therapy
- Pacemakers: For bradyarrhythmias
- ICD: For VT/VF prevention
- CRT: For dyssynchrony in heart failure
Ablation Therapy
- Catheter ablation: For SVT, VT, AFib
- Surgical ablation: Maze procedure for AFib
- AV node ablation: With pacemaker for rate control
β οΈ Life-Threatening Arrhythmias
Some arrhythmias require immediate recognition and treatment to prevent sudden cardiac death.
Ventricular Fibrillation
- Chaotic, disorganized ventricular activity
- No cardiac output, immediate CPR required
- Treatment: Immediate defibrillation
- Prognosis: Fatal without treatment
Pulseless VT
- Organized wide complex tachycardia
- No palpable pulses, unconscious
- Treatment: Immediate defibrillation
- Prognosis: Poor without rapid intervention
π§ Key Takeaways
- Arrhythmias result from disorders of impulse formation or conduction
- Three main mechanisms: enhanced automaticity, triggered activity, reentry
- Classify by rate (brady vs tachy), origin (supraventricular vs ventricular), QRS width
- ECG is the primary diagnostic tool, supplemented by monitoring
- Management depends on stability: unstable requires immediate cardioversion
- Antiarrhythmic drugs are classified by mechanism (Vaughan Williams)
- Non-pharmacologic options include devices (pacemakers, ICDs) and ablation
- Always search for and treat reversible causes
π§ Conclusion
We've navigated the complex electrical landscape of the heart, studentβfrom the basic physiology of conduction to the dramatic presentations of life-threatening arrhythmias. Remember that arrhythmia management requires both acute intervention skills and long-term strategic thinking. I encourage you to master ECG interpretation and understand when arrhythmias become emergencies. Excellent work completing the cardiovascular section! Next, we'll move to respiratory diseases, starting with asthma and COPD.
In arrhythmias, the first question is always: "Is the patient stable?" This determines everything that follows.